A team of German and Belgian researchers has succeeded in gaining new insights into the causes of certain movement disorders and forms of dementia. Scientists including Bettina Schmid and Christian Haass from the DZNE in Munich and the LMU were able to reproduce…

A three molecule complex may be a target for treating Huntington’s disease, a genetic disorder affecting the brain. This finding by an international research team including scientists from the German Center for Neurodegenerative Diseases (DZNE) in Bonn and the…

The chemical compound known as “methylene blue” is a potential candidate for treating Alzheimer’s, as it prevents the harmful clumping of so-called tau proteins typically associated with this disease. However, until now it was unknown why methylene blue had this…

Goettingen, February 11th, 2013. When proteins get “out of shape”, the consequences can be fatal. They lose their function and in some cases form insoluble, toxic clumps that damage other cells and can cause severe diseases such as Alzheimer’s or Parkinson’s.…

Scientists identify enigmatic aggregates linked to neurodegenerative diseases

Magdeburg/London, January 18th, 2013. The brain can recall memories faster than previously assumed. A team of experts under the direction of neuroscientist Emrah Düzel, who is based in Magdeburg, Germany, was able to show this through a series of memory tests.…

From January 2013: New site speaker at DZNE Witten

Federal Minister Schavan inaugurates new DZNE and University of Ulm institutes

Bonn, December 20th, 2012. Scientists at the German Center for Neurodegenerative Diseases (DZNE) in Bonn have gained new insights into the early phase of the brain’s development. In cooperation with researchers of the Max Planck Institute of Neurobiology,…

Bonn, December 19th, 2012. Researchers in Bonn, Germany, have identified a protein as a potential target for the treatment of Alzheimer’s disease. The molecular complex is part of the immune system and a driving force for inflammatory responses of the brain.…